Skip to main content

Palihapitiya Chamath's Form 4 filing

Prokidney Corp. (PROK) · filed Oct 26, 2023

Accession no.
0001104659-23-111828
Filed
Oct 26, 2023, 9:00 PM ET
Trade date
Oct 24-26, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market sales total $567.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Palihapitiya ChamathCIK 000171545010% Owner
SC Master Holdings, LLCCIK 000185102410% Owner
SC PIPE Holdings LLCCIK 000193869610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2023Class A ordinary sharesSSaleDisposed−176,300$1.75F1−$308,613.157,664,673Indirect
Oct 25, 2023Class A ordinary sharesSSaleDisposed−67,213$1.76F3−$118,382.267,597,460Indirect
Oct 26, 2023Class A ordinary sharesSSaleDisposed−77,960$1.80F4−$140,577.477,519,500Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6400 to $1.8650. The reporting person undertakes to provide ProKidney Corp. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.6600 to $1.8450. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.7500 to $1.8350. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)